Miraculins Raises $505K in Private Placement | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Miraculins has completed a private placement of 10.2 million units, raising C$510,000 (US$505,000) in proceeds.

The Winnipeg, Canada-based diagnostics firm said that it has sold the units at C$.05 each. The units are comprised of one common share and one share purchase warrant. Each warrant entitles the holder to purchase one share at a price of C$.10 for a period of 12 months after the warrant is issued.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.